SEARCH

SEARCH BY CITATION

References

  • 1
    Dorn CR, Taylor DON, Hibbard HH. Epozootiologic characteristics of canine and feline leukaemia and lymphoma. Am J Vet Res 1967;28:9931001.
  • 2
    Hardy WD. Hematopoietic tumors of cats. J Am Anim Hosp Assoc 1981;17:921940.
  • 3
    Schneider R. Comparison of age- and sex-specific incidence rate patterns of the leukaemia complex in the cat and dog. J Natl Cancer Inst 1983;70:971977.
  • 4
    Louwerens M, London CA, Pedersen NC, et al. Feline lymphoma in the post-feline leukaemia virus era. J Vet Intern Med 2005;19:329335.
  • 5
    Cotter SM. Treatment of lymphoma and leukemia with cyclophosphamide, vincristine and prednisone: II. Treatment of cats. J Am Anim Hosp Assoc 1983;19:166172.
  • 6
    Jeglum KA, Whereat A, Young K. Chemotherapy of lymphoma in 75 cats. J Am Vet Med Assoc 1987;190:174178.
  • 7
    Mooney SC, Hayes AA, Matus RE, et al. Treatment and prognostic factors in lymphoma in cats: 103 cases (1977–1981). J Am Vet Med Assoc 1989;194:696699.
  • 8
    Mahony OM, Moore AS, Cotter SM, et al. Alimentary lymphoma in cats: 28 cases (1988–1993). J Am Vet Med Assoc 1995;207:15931597.
  • 9
    Moore AS, Cotter SM, Frimberger AE, et al. A comparison of doxorubicin and COP for maintenance of remission in cats with lymphoma. J Vet Intern Med 1996;10:372375.
  • 10
    Vail DM, Moore AS, Ogilvie GK, Volk LM. Feline lymphoma (145 cases): Proliferation indices, cluster of differentiation 3 immunoreactivity, and their association with prognosis in 90 cats. J Vet Intern Med 1998;12:349354.
  • 11
    Link M, Hirschberger J. Feline lymphoma: Treatment results and prognostic factors (18 cats). Tierärztl Prax 2000;28:8793.
  • 12
    Malik R, Gabor LJ, Foster SF, et al. Therapy of Australian cats with lymphosarcoma. Aust Vet J 2001;79:808817.
  • 13
    Kristal O, Lana SE, Ogilvie GK, et al. Single agent chemotherapy with doxorubicin for feline lymphoma: A retrospective study of 19 cases (1994–1997). J Vet Intern Med 2001;15:125130.
  • 14
    Teske E, Van Straten G, Van Noort R, et al. Chemotherapy with cyclophosphamid, vincristine, and prednisolon (COP) in cats with malignant lymphoma: New results with an old protocol. J Vet Intern Med 2002;16:179186.
  • 15
    Milner RJ, Peyton J, Cooke K, et al. Response rates and survival times for cats with malignant lymphoma treated with the University of Wisconsin-Madison chemotherapy protocol: 38 cases (1996–2003). J Am Vet Med Assoc 2005;227:11181122.
  • 16
    Chun R, Garrett LD, Vail DM. Evaluation of a high-dose chemotherapy protocol with no maintenance therapy for dogs with lymphoma. J Vet Intern Med 2000;14:120124.
  • 17
    Moore AS, Cotter SM, Rand WM, et al. Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma. J Vet Intern Med 2001;15:348354.
  • 18
    Garrett LD, Thamm DH, Chun R, et al. Evaluation of a 6-month chemotherapy protocol with no maintenance therapy for dogs with lymphoma. J Vet Intern Med 2002;16:704709.
  • 19
    Morrison-Collister KE, Rassnick KM, Northrup NC, et al. A combination chemotherapy protocol with MOPP and CCNU consolidation (Tufts VELCAP-SC) for the treatment of canine lymphoma. Vet Comp Oncol 2003;1:180190.
  • 20
    Simon D, Nolte I, Eberle N, Abbrederis N, et al. Treatment of dogs with lymphoma using a 12-week, maintenance-free combination chemotherapy protocol. J Vet Intern Med 2000;20:948954.
  • 21
    Vail DM. Feline lymphoma and leukemia. In: Withrow SJ, Vail DM, eds. Withrow and MacEwen's Small Animal Clinical Oncology. St. Louis, MO: Saunders; 2007:733756.
  • 22
    Mooney SC, Hayes AA. Lymphoma in the cat: An approach to diagnosis and management. Semin Vet Med Surg (Small Anim) 1986;1:5157.
  • 23
    Veterinary Co-Operative Oncology Group. Veterinary Co-Operative Oncology Group—Common terminology criteria for adverse events (VCOG-CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0. Vet Comp Oncol 2004;2:194213.
  • 24
    Gabor LJ, Malik R, Canfield PJ. Clinical and anatomical features of lymphosarcoma in 118 cats. Aust Vet J 1998;76:725732.
  • 25
    Gabor LJ, Jackson ML, Trask B, et al. Feline leukaemia virus status of Australian cats with lymphosarcoma. Aust Vet J 2001;79:476481.
  • 26
    Zwahlen CH, Lucroy MD, Kraegel SA, et al. Results of chemotherapy for cats with alimentary malignant lymphoma: 21 cases (1993–1997). J Am Vet Med Assoc 1998;213:11441149.
  • 27
    Shelton GH, Grant CK, Cotter SM, et al. Feline immunodeficiency virus and feline leukemia virus infections and their relationships to lymphoid malignancies in cats: A retrospective study (1968–1988). J Acquir Immune Defic Syndr 1990;3:623630.
  • 28
    Callanan JJ, Jones BA, Irvine J, et al. Histologic classification and immunophenotype of lymphosarcomas in cats with naturally and experimentally acquired feline immunodeficiency virus infections. Vet Pathol 1996;33:264272.
  • 29
    Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: Increasing the value of clinical research for decision making in clinical and health policy. JAMA 2003;290:16241632.
  • 30
    Glasgow RE, Magid DJ, Beck A, et al. Practical clinical trials for translating research to practice: Design and measurement recommendations. Med Care 2005;43:551557.